Dose Selection for a Direct and Selective Factor IXa Inhibitor and its Complementary Reversal Agent: Translating Pharmacokinetic and Pharmacodynamic Properties of the REG1 System to Clinical Trial Design
Titel:
Dose Selection for a Direct and Selective Factor IXa Inhibitor and its Complementary Reversal Agent: Translating Pharmacokinetic and Pharmacodynamic Properties of the REG1 System to Clinical Trial Design
Auteur:
Povsic, T. J. Cohen, M. G. Chan, M. Y. Zelenkofske, S. L. Wargin, W. A. Harrington, R. A. Alexander, J. H. Rusconi, C. P. Becker, R. C.